Search results
«Байєр» в Україні є частиною глобального концерну «Байєр АГ» (Bayer AG) із штаб-квартирою в Леверкузені (Німеччина). В Україні компанія розпочала роботу з 1992 року.
Key Past Events. In addition to our Annual Stockholders’ Meeting, we also host quarterly earnings calls, capital market days, roadshows, and participate in broker conferences throughout the year to keep our investors informed about our performance. Below you will find an up-to-date calendar with the date, location and further details of each ...
May 21, 2024 · In 2023, we started redesigning Bayer around our mission: Health for all, Hunger for none. That began with an overhaul of our operating model: to deliver faster innovation and a better experience for the farmers, patients and consumers who depend on #TeamBayer. We’re putting an end to the hierarchical model and putting more power in the hands ...
The integrated Annual Report combines our financial reporting and our nonfinancial statement, which contains all material sustainability information required by commercial law. Our aim is to elucidate the interactions between financial, ecological and societal factors and underline their influence on our company’s long-term success.
Chi siamo. Bayer - azienda globale con competenze chiave nelle Life Science: Salute e Nutrizione - è presente in Italia da più di 120 anni. Conta un fatturato di 1,06 miliardi di euro, circa 1.500 dipendenti e un sito produttivo sul territorio nazionale con un impianto fra i più avanzati al mondo (dati dicembre 2022). Le attività del Gruppo ...
Apr 12, 2022 · In 1958, Bayer was registered in Hong Kong as an independent trading entity – known as Bayer Far East Service Co Ltd. Since then, it has become a significant investor in mainland China and Hong Kong SAR. In Hong Kong, Bayer combines the business activities of the Pharmaceuticals and Consumer Health divisions. Last Updated: Tuesday, April 12 ...
Bayer will showcase latest prostate cancer data for darolutamide and targeted alpha therapy radium-223 dichloride / Bayer will also present a late-breaking abstract of BAY 2927088 in patients with HER2-mutant non-small cell lung cancer (NSCLC), …
